WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'6201 Infant (under 12 months) mortality rate: 232
GDP / capita (US$): 11'6961 Child (under 5 years) mortality rate: 272

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 10'404  10'277  10'148  10'017  9'884  8'663  7'245  5'826 
Births 217  218  219  219  220  217  217  200 
Surviving infants 211  212  213  213  214  208  205  184 
Pop. less than 5 years 1'061  1'063  1'065  1'068  1'070  1'027  998  883 
Pop. less than 15 years 3'142  3'134  3'127  3'123  3'115  3'027  2'791  2'480 
Female 15-49 years 2'715  2'688  2'659  2'627  2'594  2'244  1'792  1'366 

Number of reported case

(Click for retrospective incidence data for Dominican Republic (the))
Diphtheria 52  27  187 
Japanese encephalitis
Measles 254  3'477  9'760 
Mumps 498  2'760 
Pertussis 17  11  37  18  40  227  558 
Polio* 11  148 
Rubella 818 
Rubella (CRS)
Tetanus (neonatal) 12  14 
Tetanus (total) 55  40  45  50  59  25  56  113 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominican Republic (the))
Vaccine year result method % card seen                                                
BCG 2009  94  MICS     98  100  99*  98  96  90  68  29 
DTP1 2009  90  MICS     91  93  91  96  85 
DTP3 2009  64  MICS     83  85  84  88  82  78  69  36 
HepB_BD          78  74  82  80  73 
HepB3 2005  74  DHS   62  80  74  80  84  85  68 
Hib3 2005  74  DHS   62  75  70  71  81  77 
JapEnc         
MCV 2009  72  MICS     83  88  88  87  90  88  96  30 
MCV2         
PCV1          88  33 
PCV3         
Pol3 2009  65  MICS     82  85  84  86  85  67  90  46 
Rota1          81  59 
Rota_last          68  21 
Rubella1          83  88  88  87  90 
TT2plus 2001  86  DHS   50  87  90  63  13  63  25 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominican Republic (the))
BCG 98  99  99  98  96  90  70  29 
DTP1 91  92  91  96  85  91  87  61 
DTP3 83  85  84  88  82  78  69  36 
HepB3 80  74  80  84  85  68 
HepB_BD 78  74  82  80  73 
Hib3 75  70  71  81  77 
MCV 79  79  79  79  79  85  70  30 
MCV2
PAB 90  90  90  87  86  48  60  23 
PCV3
Pol3 82  85  84  86  85  74  90  46 
Rota_last 68  20 

Number of districts in the country 155  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 31
From 80 to 89% 18
From 50 to 79% 40
Less than 50% 11
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV Yes From September 2014
HepB birth; Yes and risk groups at contact, +1, +6 months
Influenza 6-24 months; >= 65 years; and risk groups and PW
MMR 12 months; Yes
MR In case of MMR stock outs
OPV 2, 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 65 years;
Rotavirus 2, 4 months; Yes
Td 1st contact; +4-6 weeks; +6 months; +1, +1 year; Yes every 10 years

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2010-2015  2006-2010  2006-2010  2006-2010  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 68      75      26 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No       

System performance

Total Nº districts in country number 155  155  155  155  155  155   
Nº districts with DTP3 coverage >=80% number 76  75  68  93  65  67  29 
% of districts with DTP3 coverage >=80% From 0 to 100% 49  48  44  60  42  43   
Nº districts with measles (MCV1) coverage >=95% number 28  46  47  38  42  42   
% of districts with MCV1 coverage >=95% From 0 to 100% 18  30  30  25  27  27   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No    Yes   

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  50  100  90  90  94 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.